Curative Biotechnology, Inc.

Curative Biotechnology, Inc.verified

CUBT

Price:

$0.0087

Market Cap:

$7.86M

Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504...[Read more]

Industry

Biotechnology

IPO Date

1998-03-30

Stock Exchange

PNK

Ticker

CUBT

The Enterprise Value as of November 2024 (TTM) for Curative Biotechnology, Inc. (CUBT) is 10.02M

According to Curative Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.02M. This represents a change of -44.34% compared to the average of 18.01M of the last 4 quarters.

Curative Biotechnology, Inc. (CUBT) Historical Enterprise Value (quarterly & annually)

How has CUBT Enterprise Value performed in the past?

The mean historical Enterprise Value of Curative Biotechnology, Inc. over the last ten years is 6.68M. The current 10.02M Enterprise Value has changed 14.91% with respect to the historical average. Over the past ten years (40 quarters), CUBT's Enterprise Value was at its highest in in the March 2024 quarter at 26.50M. The Enterprise Value was at its lowest in in the December 2021 quarter at -493350.84.

Quarterly (TTM)
Annual

Average

6.68M

Median

701.60K

Minimum

230.90K

Maximum

25.38M

Curative Biotechnology, Inc. (CUBT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Curative Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.31%

Maximum Annual Enterprise Value = 25.38M

Minimum Annual Increase = -61.14%

Minimum Annual Enterprise Value = 230.90K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202316.31M30.95%
202212.45M-50.94%
202125.38M147.26%
202010.26M1.31%
2019726.43K214.41%
2018231.05K0.06%
2017230.90K-12.22%
2016263.03K-61.14%
2015676.78K174.38%
2014246.66K-4.05%

Curative Biotechnology, Inc. (CUBT) Average Enterprise Value

How has CUBT Enterprise Value performed in the past?

The current Enterprise Value of Curative Biotechnology, Inc. (CUBT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

18.05M

5-year avg

13.03M

10-year avg

6.68M

Curative Biotechnology, Inc. (CUBT) Enterprise Value vs. Peers

How is CUBT’s Enterprise Value compared to its peers?

Curative Biotechnology, Inc.’s Enterprise Value is less than Biotron Limited (16.98M), greater than Bioasis Technologies Inc. (397.14K), less than Covalon Technologies Ltd. (93.17M), greater than Mosaic ImmunoEngineering Inc. (8.29M), less than Ceapro Inc. (16.01M), less than Cellectis S.A. (115.55M), less than Resverlogix Corp. (17.90M), less than Small Pharma Inc. (34.51M),

Build a custom stock screener for Curative Biotechnology, Inc. (CUBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curative Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curative Biotechnology, Inc. (CUBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curative Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Curative Biotechnology, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Curative Biotechnology, Inc. (CUBT)?

What is the 3-year average Enterprise Value for Curative Biotechnology, Inc. (CUBT)?

What is the 5-year average Enterprise Value for Curative Biotechnology, Inc. (CUBT)?

How does the current Enterprise Value for Curative Biotechnology, Inc. (CUBT) compare to its historical average?